Fenben for cancer destroys the microtubules that sustain the structure of a cancer cell and helps the body remove the cells. It also boosts the production of a gene, called p53, that keeps cancer cells from growing or spreading. It limits the ability of cancer cells to process sugar — a vital energy source that most cancers depend on to survive. Berberine works in tandem with fenbendazole to further weaken cancer cells by inhibiting their ability to take up glucose, which causes them to starve.
In this article, we surveyed the cancer patients’ information acquisition channels and perceptions of complementary and alternative medicine (CAM) and found that most participants acquire general cancer and fenbendazole-related information through social media communities and portal sites and YouTube. However, the information obtained is highly fragmented and of low quality. In addition, most of the patients perceive that CAM information needs to be verified by experts before being trusted, and that they must actively search for such information on their own.
The anti-proliferative effect of fenbendazole is related to inhibition of tubulin polymerization, which induces mitotic catastrophe in G2 phase. To determine whether fenbendazole affects cell-cycle progression, H460 and A549 cells were synchronized by serum starvation for 48 h and treated with 1 uM FZ for different periods of time. Cells were then analyzed by flow cytometry to detect the expression of cyclin B1, and a glucose uptake assay was performed using the fluorescent glucose analogue 2-NBDG. fenben for cancer